Skip to main content
. 2023 Jun 19;109(9):2598–2607. doi: 10.1097/JS9.0000000000000536

Table 1.

Preoperative general data of AR group and non-AR group.

Variables AR group (41 cases) Non-AR group (41 cases) T (χ 2) value P
Age, years, mean±SD 61.05±12.12 61.71±10.41 −0.264 0.792
Sex, n (%) 1.892 0.169
 Male 23 (56.1) 29 (70.7)
 Female 18 (43.9) 12 (29.3)
Preoperative biliary drainage n (%) 13 (31.7) 6 (14.6) 3.357 0.067
Diabetes, n (%) 10 (24.4) 9 (22.0) 0.069 0.794
Hemoglobin, g/l, mean±SD 118.22±15.46 117.37±17.93 0.121 0.231
White blood cell, G/l, mean±SD 6.55±3.66 7.51±2.13 −1.452 0.150
Total bilirubin, umol/l, mean±SD 60.68±72.81 114.99±148.90 1.164 0.244
Direct bilirubin, umol/l, mean±SD 45.69±96.79 96.79±132.86 1.266 0.205
Serum amylase, IU/l, mean±SD 128.97±156.64 104.05±66.35 0.833 0.405
Serum lipase, IU/l, mean±SD 212.76±356.04 171.19±189.03 0.563 0.576
Lesion location, n (%) 10.254 0.017*
Distal bile duct 5 (12.2) 15 (36.6)
 Head of pancreas 23 (56.1) 13 (31.7)
 Ampulla 5 (12.2) 9 (22.0)
 Duodenum 8 (19.5) 4 (9.8)
Size of lesion, mm, mean±SD 26.50±14.108 24.57±19.496 0.505 0.615
Diameter of pancreatic duct, mm, mean±SD 4.77±3.44 4.34±3.43 −0.446 0.656
Diameter of bile duct, mm, mean±SD 10.74±6.80 10.05±7.24 −0.268 0.713
*

Statistically significant.

AR, Augmented reality.